Clinical Trials Directory

Trials / Completed

CompletedNCT05649176

Lifestyle Intervention for Improving Insulin Resistance and Concern for Health

Lifestyle Intervention for Improving Metabolic and Motivational Outcomes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to test the effect of a diet and exercise program in older adults with insulin resistance and a motivation disorder known as apathy. The main questions the study aims to answer are: 1. Does the diet and exercise program improve insulin resistance and apathy? 2. Does the addition of soybean to the diet enhance the effect? Participants will be given all meals for 12 weeks and will exercise under supervision. They will undergo a test of insulin sensitivity and complete questionnaires. Researchers will compare the groups given: 1. A diet to moderate the blood glucose response that contains soybean; and 2. A diet to moderate the blood glucose response that does not contain soybean.

Detailed description

This randomized trial will examine the blood glucose moderating effect of a diet and exercise program in 40 older adults with obesity, insulin resistance, and apathy. The primary objective of this study is to examine the effect of a diet and exercise program on insulin sensitivity and apathy and determine if the addition of soybean to the diet enhances the effect. The primary outcomes of the study are insulin sensitivity measured using the hyperinsulinemic euglycemic clamp test and apathy evaluated using the Apathy Evaluation Scale.

Conditions

Interventions

TypeNameDescription
OTHERDiet without soyThe diet is designed to moderate the blood glucose response with a similar macronutrient composition as the experimental diet but does not contain soy.
OTHERDiet with soyThe diet is designed to moderate the blood glucose response with a similar macronutrient composition as the comparator diet but contains soy.

Timeline

Start date
2023-02-13
Primary completion
2025-10-27
Completion
2025-10-27
First posted
2022-12-13
Last updated
2025-12-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05649176. Inclusion in this directory is not an endorsement.